MedTrace Logo

Trauma Screening and Supplementation

NCT03658278 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2023-09-21

No results posted yet for this study

Summary

The purpose of the proposed study is twofold: 1) The investigators will evaluate ultrasound imaging to screen trauma patients to identify patients at increased risk of postoperative complications associated with sarcopenia. 2) The investigators will evaluate a commercially-available oral nutritional supplement that has previously been evaluated in critically-ill intensive care patients and shown benefit for decreasing complications including decreased wound healing complications, decreased pressure ulcers, decreased skeletal muscle loss due to immobilization, and decreased one-year mortality.

Conditions

  • Trauma
  • Nutritional Deficiency
  • Wound Heal

Interventions

DIETARY_SUPPLEMENT

Juven

Nutritional supplement (Juven) will be consumed daily per manufacturer recommendations

Sponsors & Collaborators

  • Orthopaedic Trauma Association

    collaborator OTHER

  • Michael C Willey

    lead OTHER

Principal Investigators

  • Nathan Hendrickson, MD · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-15
Primary Completion
2019-11-13
Completion
2019-11-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03658278 on ClinicalTrials.gov